Class: NSAIDs, Analgesic

Manufacturer: ATOZ Pharmaceutical Pvt. Ltd, No12 Balaji Nagar, Ambattur, Chennai – 600 053 India.

Dosage Form: Tablet

Similar Brands:

Uses:

Resolution of inflammation and pain due to bone and soft tissue injury. Resolution of post-operative inflammation, oedema and pain.

Dosage:

The maximum recommended dose of ZULU-SP is two tablets daily, taken as one tablet in the morning and one tablet in the evening or as directed by physician. Not recommended for children aged less than 18 years. Mode of administration: oral.

Side Effects:

Undesirable effects may be minimized by using the lowest effective dose for the shortest duration necessary to control symptoms. Concomitant use with NSAIDs, including COX-2 selective inhibitors, should be avoided. It should not be combined with other analgesic medications that contain paracetamol and should be given with care to patients with impaired kidney or liver function.

Warnings & Precautions:

Caution is required if administered to patients suffering from, or with a previous history of, bronchial asthma since NSAIDs have been reported to precipitate bronchospasm in such patients.

Pregnancy & Lactation:

Congenital abnormalities have been reported in association with NSAID administration in humans; the regular use of NSAIDS during the las trimester of pregnancy may decrease uterine tone and contraction. NSAIDs can appear in breast milk in very low concetrations. NSAIDs should, if possible, be avoided when breastfeeding.

Drug Interactions:

Avoid concomitant use of two or more NSAIDs (including aspirin)as this may increase the risk of adverse effects. Reduced diuretic effect. Diuretics can increase the risk of nephrotoxicity of NSAIDs. The anticoagulant effect of warfarin and other coumarins may be enhanced by prolonged regular use of paracetamol, with increased risk of bleeding. The effect appears to increase as the dose of paracetamol is increased, but can occur with doses as low as 1.5-2gm paracetamol per day for at least 5-7 days. Occasional doses have no significant effect. Serratiopeptidase may interact with medications that slow blood clotting (anticoagulant/antiplatelate drugs).

Contraindications:

Patients sensitive to aceclofenac, paracetamol, serratiopeptidase or to any of the excipients of the product. Patients with a history of or active recurrent peptic ulce/haemorrhage (two or more distinct episodes of proven ulceration or bleeding). Patients who have previously shown hypersensitivity reactions (e.g asthma, rhinitis, angio-oedema or urticaria) in response to ibuprofen, aspirin or other NSAIS.

Price: Ksh 1040

Notes:

Pack Size: 20s

Overdose

Liver damage is possible in adults who have taken 10g or more of paracetamol. Ingestion of 5g or more of paracetamol may lead to liver damage if the patient has risk factors.

Treatments: immediate treatment is essential in the management of overdosage. Despite a lack of significant early symptoms, patients should be referred to a hospital urgently for immediate medical attention. Patients should be treated symptomatically as required. Within 1 hour of ingestion of a potentially toxic amount, activated charcoal should be considered. Alternatively, in adults, gastric lavage should be considered within 1 hour of ingestion of a potentially life-threatening overdose

Effects on ability to drive and use machines

When driving vehicle or operating machines it should be taken into account that dizziness and fatigue may occasionally occur.

Marketed by: INNOCIA lifesciences Pvt. Ltd block A, No 12 Balaji Nagar, Ambattur, Chennai – 600 053 India .